|
|
|
 |
 |
TOLENORM
- Solution
for
Vitiligo and Hypopigmentary problems
|
|
| |
| What
Is Vitiligo? |
Vitiligo
is an acquired primary, usually progressive, melanocytopenia
of obscure etiology manifesting circumscribed depigmented
patches. It affects 1% of the world population of either
sex. Vitiligo (vit-ill-eye-go) is a pigmentation disorder
in which melanocytes (the cells that make pigment) in
the skin, the tissues that line the inside of the mouth
and nose and genital and rectal areas (mucous membranes),
and the retina of the eyes are destroyed. As a result,
white patches of skin appear on different parts of the
body. The hair that grows in areas affected by Vitiligo
may turn white. |
| |
The
cause of Vitiligo is not known, but Doctors and Researchers
have several different theories. One theory is that
people develop antibodies that destroy the melanocytes
in their own bodies. Another theory is that melanocytes
destroy themselves. Finally, some people have reported
that a single event such as sunburn or emotional distress
triggered Vitiligo; however, these events have not been
scientifically proven to cause Vitiligo. |
| |
While
most treatment methodologies are cosmetic and attempt
to camaflouge, Chemotherapy with PUVA has not been without
side effects. Herbal preparations TOLENORM
Oil and
TOLENORM Ointment
from Dr. JRK 's Siddha
Research & Pharmaceuticals Pvt. Ltd
offers a safe, effective and long term solution to the
problem. |
| |
|
|
Who
Is Affected by Vitiligo? |
| |
About
1 to 2 percent of the world's population, or 40 to 50
million people, have Vitiligo. In the United States,
2 to 5 million people have the disorder. Ninety-five
percent of people who have Vitiligo develop it before
their 40th birthday. The disorder affects all races
and both sexes equally. |
| |
Vitiligo
seems to be more common in people with certain autoimmune
diseases (diseases in which a person's immune system
reacts against the body's own organs or tissues). These
autoimmune diseases include hyperthyroidism (an overactive
thyroid gland), adrenocortical insufficiency (the adrenal
gland does not produce enough of the hormone called
corticosteroid), alopecia areata (patches of baldness),
and pernicious anemia (a low level of red blood cells
caused by failure of the body to absorb vitamin B12).
Scientists do not know the reason for the association
between Vitiligo and these autoimmune diseases. However,
most people with Vitiligo have no other autoimmune disease.
|
| |
Vitiligo
may also be hereditary, that is, it can run in families.
Children whose parents have the disorder are more likely
to develop Vitiligo. However, most children will not
get Vitiligo even if a parent has it, and most people
with Vitiligo do not have a family history of the disorder.
|
| |
What
Are the Symptoms of Vitiligo? |
| |
People
who develop Vitiligo usually first notice white patches
(depigmentation) on their skin. These patches are more
common in sun-exposed areas, including the hands, feet,
arms, face, and lips. Other common areas for white patches
to appear are the armpits and groin and around the mouth,
eyes, nostrils, navel, and genitals. Vitiligo generally
appears in one of three patterns. In one pattern (focal
pattern), the depigmentation is limited to one or only
a few areas. Some people develop depigmented patches
on only one side of their bodies (segmental pattern).
But for most people who have Vitiligo, depigmentation
occurs on different parts of the body (generalized pattern).
In addition to white patches on the skin, people with
Vitiligo may have premature graying of the scalp hair,
eyelashes, eyebrows, and beard. People with dark skin
may notice a loss of color inside their mouths. |
| |
Will
the Depigmented Patches Spread? |
| |
There
is no way to predict if Vitiligo will spread. For some
people, the depigmented patches do not spread. The disorder
is usually progressive, however, and over time the white
patches will spread to other areas of the body. For
some people, Vitiligo spreads slowly, over many years.
For other people, spreading occurs rapidly. Some people
have reported additional depigmentation following periods
of physical or emotional stress. |
|
| |
|
|
|
|